About: The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 May 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2004 (uk) im Mai 2004 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 15 May 2004 (en) artículu científicu espublizáu en mayu de 2004 (ast)
publication date	wds:Q80810942-92C31457-4915-4631-A7B1-CBB0AF22D66C
publication date	2004-05-15 00:00:00Z (xsd:dateTime)
cites work	wds:Q80810942-039C621F-1F64-4114-8260-D65BCC01FA1E wds:Q80810942-07F90169-2D60-44DC-8E3A-81D39DB2911C wds:Q80810942-0863860A-BA70-4C7B-A8A1-38B5EFAC26F5 wds:Q80810942-098B02D1-A8CB-48BF-AC56-7C422D4408BF wds:Q80810942-24DFEE49-AED2-4D31-A8F4-08ACD11ED0BC wds:Q80810942-267E670F-4E3D-4B3A-964D-6FBF4BC58474 wds:Q80810942-28455876-077D-434D-ABAE-629B1CFDA9E2 wds:Q80810942-2B587DB8-013C-4C90-BCFF-7C752CE9C12E wds:Q80810942-372E4EFC-901E-4342-A979-611E3B466FF4 wds:Q80810942-4F230E6C-351E-4A88-9A9F-4566B228F594 wds:Q80810942-5231A5B5-BE54-495B-9416-B3A63FB9600A wds:Q80810942-53AFBB6C-C1B2-47E1-AF65-B1F35AE6F894 wds:Q80810942-5ADF39B9-0BBE-4C8F-8E4D-C07F47410A28 wds:Q80810942-60D57F21-EE32-4AAF-B62D-4F5F31E109DE wds:Q80810942-7ACEE7B3-2FA8-4399-8285-9D46B6105CCC wds:Q80810942-81DC531A-6BEB-443F-8559-3EA65666EDFA wds:Q80810942-875F23B9-FBB6-4375-92C5-C2DCC94BAAB7 wds:Q80810942-87E7A638-B1F7-49C9-A962-4582EE1C0923 wds:Q80810942-8B444BFE-FC30-4A97-BFFF-49C03FAFD5BE wds:Q80810942-A07CECA8-3A8D-46E1-9ECD-FB7D8ACD20ED wds:Q80810942-A681C9ED-A869-4C35-8DA0-F39FE2E5FB54 wds:Q80810942-A81D4AE6-7FA8-46CD-90DC-87E1E8317B3D wds:Q80810942-B04EDC94-BBD4-43CB-BDF4-417676226DDB wds:Q80810942-B05B9DE4-F5D7-4203-A179-50AE88DC3F1A wds:Q80810942-B365CE66-F1DD-4432-9D70-B317B59C2F7D wds:Q80810942-B8BB40D5-A21C-4B91-8A66-607B7D7B91BA wds:Q80810942-BC547A63-731E-4840-B6BA-057B0193A36E wds:Q80810942-D0E02AEC-4659-4AB6-8846-3B3D0A62E2F2 wds:Q80810942-D7BDDA55-E226-41EF-B549-584B89DA0D4A wds:Q80810942-E0E875EB-EF70-405C-9C19-DA89764F0203 wds:Q80810942-F77C50AF-DDD0-498A-9F3C-17291FE051E6 wds:Q80810942-FAE04F7A-3A7E-4296-95A0-EAF16A5DEC4B
cites work	Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films Fas and Fas ligand: lpr and gld mutations Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Apoptosis in rheumatoid arthritis synovium Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Regulation of apoptosis in the immune system Induction of Fas-dependent apoptosis in synovial infiltrating cells in rheumatoid arthritis The apoptosis-1/Fas protein in human systemic lupus erythematosus Preliminary criteria for clinical remission in rheumatoid arthritis Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations A modified scleroderma skin scoring method Autoimmune disease. A problem of defective apoptosis Activation of dermal connective tissue in scleroderma. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patients Apoptosis in the immune system Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome
author name string	wds:Q80810942-123C40D4-B0A4-4E15-8503-DFD7B3A3A9D3 wds:Q80810942-3BED419B-1C80-4714-9D8A-B1FB0E540CC0 wds:Q80810942-4A984045-A352-4909-ABBD-EBC8F2DAD251 wds:Q80810942-60699C42-CF0C-4026-9EE6-2FF7F7491718
author name string	Murat Duman Aşkin Ateş Murat Turgay Gülay Kinikli
rdfs:label	The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis (en) The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis (nl)
skos:prefLabel	The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis (en) The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis (nl)
name	The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis (en) The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis (nl)
title	wds:Q80810942-56A46515-10D7-47F5-BBD3-7BA9015A75AF
title	The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis (en)
page(s)	wds:Q80810942-BF150AE1-A5E1-4A60-9404-823A93E14A8B
page(s)	421-425
instance of	wds:Q80810942-A6CDB72E-5371-4024-BC6F-C2FA7369F15B
instance of	scholarly article
main subject	wds:Q80810942-19791C5C-F1CA-43D9-838A-D40CBF7E51E6
main subject	rheumatoid arthritis
PubMed ID	wds:Q80810942-E6222489-AAF1-4CE0-B55E-38561A14D7D9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15459814
PubMed ID	15459814
published in	wds:Q80810942-0710BDBE-E45D-4403-8F8B-20C3E2AD3522
published in	Clinical Rheumatology
issue	wds:Q80810942-CA38162A-A4D2-4D85-A183-6EE20EF79BDF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software